These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 17712331)

  • 21. Epidermal growth factor receptor (EGFR)-retargeted measles virus strains effectively target EGFR- or EGFRvIII expressing gliomas.
    Paraskevakou G; Allen C; Nakamura T; Zollman P; James CD; Peng KW; Schroeder M; Russell SJ; Galanis E
    Mol Ther; 2007 Apr; 15(4):677-86. PubMed ID: 17299404
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oncolytic efficacy and enhanced safety of measles virus activated by tumor-secreted matrix metalloproteinases.
    Springfeld C; von Messling V; Frenzke M; Ungerechts G; Buchholz CJ; Cattaneo R
    Cancer Res; 2006 Aug; 66(15):7694-700. PubMed ID: 16885371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of T cells as carriers for systemic measles virotherapy in the presence of antiviral antibodies.
    Ong HT; Hasegawa K; Dietz AB; Russell SJ; Peng KW
    Gene Ther; 2007 Feb; 14(4):324-33. PubMed ID: 17051248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeted measles virus vector displaying echistatin infects endothelial cells via alpha(v)beta3 and leads to tumor regression.
    Hallak LK; Merchan JR; Storgard CM; Loftus JC; Russell SJ
    Cancer Res; 2005 Jun; 65(12):5292-300. PubMed ID: 15958576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of a vaccine strain of measles virus genetically engineered to produce carcinoembryonic antigen as a novel therapeutic agent against glioblastoma multiforme.
    Phuong LK; Allen C; Peng KW; Giannini C; Greiner S; TenEyck CJ; Mishra PK; Macura SI; Russell SJ; Galanis EC
    Cancer Res; 2003 May; 63(10):2462-9. PubMed ID: 12750267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic potential of oncolytic measles virus: promises and challenges.
    Galanis E
    Clin Pharmacol Ther; 2010 Nov; 88(5):620-5. PubMed ID: 20881957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene therapy for prostate cancer delivered by ovine adenovirus and mediated by purine nucleoside phosphorylase and fludarabine in mouse models.
    Voeks D; Martiniello-Wilks R; Madden V; Smith K; Bennetts E; Both GW; Russell PJ
    Gene Ther; 2002 Jun; 9(12):759-68. PubMed ID: 12040457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measles virus selectively blind to signaling lymphocyte activation molecule as a novel oncolytic virus for breast cancer treatment.
    Sugiyama T; Yoneda M; Kuraishi T; Hattori S; Inoue Y; Sato H; Kai C
    Gene Ther; 2013 Mar; 20(3):338-47. PubMed ID: 22717740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Infected cell carriers: a new strategy for systemic delivery of oncolytic measles viruses in cancer virotherapy.
    Iankov ID; Blechacz B; Liu C; Schmeckpeper JD; Tarara JE; Federspiel MJ; Caplice N; Russell SJ
    Mol Ther; 2007 Jan; 15(1):114-22. PubMed ID: 17164782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Demonstration of anti-tumor activity of oncolytic measles virus strains in a malignant pleural effusion breast cancer model.
    Iankov ID; Msaouel P; Allen C; Federspiel MJ; Bulur PA; Dietz AB; Gastineau D; Ikeda Y; Ingle JN; Russell SJ; Galanis E
    Breast Cancer Res Treat; 2010 Aug; 122(3):745-54. PubMed ID: 19894113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dual therapy of ovarian cancer using measles viruses expressing carcinoembryonic antigen and sodium iodide symporter.
    Hasegawa K; Pham L; O'Connor MK; Federspiel MJ; Russell SJ; Peng KW
    Clin Cancer Res; 2006 Mar; 12(6):1868-75. PubMed ID: 16551872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo antitumor activity by dual stromal and tumor-targeted oncolytic measles viruses.
    Jing Y; Chavez V; Khatwani N; Ban Y; Espejo AP; Chen X; Merchan JR
    Cancer Gene Ther; 2020 Dec; 27(12):910-922. PubMed ID: 32231231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibiotic-mediated chemoprotection enhances adaptation of E. coli PNP for herpes simplex virus-based glioma therapy.
    Bharara S; Sorscher EJ; Gillespie GY; Lindsey JR; Hong JS; Curlee KV; Allan PW; Gadi VK; Alexander SA; Secrist JA; Parker WB; Waud WR
    Hum Gene Ther; 2005 Mar; 16(3):339-47. PubMed ID: 15812229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic therapy of disseminated myeloma in passively immunized mice using measles virus-infected cell carriers.
    Liu C; Russell SJ; Peng KW
    Mol Ther; 2010 Jun; 18(6):1155-64. PubMed ID: 20234340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Wild-type measles virus infection upregulates poliovirus receptor-related 4 and causes apoptosis in brain endothelial cells by induction of tumor necrosis factor-related apoptosis-inducing ligand.
    Abdullah H; Brankin B; Brady C; Cosby SL
    J Neuropathol Exp Neurol; 2013 Jul; 72(7):681-96. PubMed ID: 23771216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complex interactions between the replicating oncolytic effect and the enzyme/prodrug effect of vaccinia-mediated tumor regression.
    McCart JA; Puhlmann M; Lee J; Hu Y; Libutti SK; Alexander HR; Bartlett DL
    Gene Ther; 2000 Jul; 7(14):1217-23. PubMed ID: 10918490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Engineering oncolytic measles virus to circumvent the intracellular innate immune response.
    Haralambieva I; Iankov I; Hasegawa K; Harvey M; Russell SJ; Peng KW
    Mol Ther; 2007 Mar; 15(3):588-97. PubMed ID: 17245355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of the Aurora A kinase augments the anti-tumor efficacy of oncolytic measles virotherapy.
    Iankov ID; Kurokawa CB; D'Assoro AB; Ingle JN; Domingo-Musibay E; Allen C; Crosby CM; Nair AA; Liu MC; Aderca I; Federspiel MJ; Galanis E
    Cancer Gene Ther; 2015 Sep; 22(9):438-44. PubMed ID: 26272026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prodrug bioactivation and oncolysis of diffuse liver metastases by a herpes simplex virus 1 mutant that expresses the CYP2B1 transgene.
    Pawlik TM; Nakamura H; Mullen JT; Kasuya H; Yoon SS; Chandrasekhar S; Chiocca EA; Tanabe KK
    Cancer; 2002 Sep; 95(5):1171-81. PubMed ID: 12209705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Live attenuated measles virus vaccine induces apoptosis and promotes tumor regression in lung cancer.
    Zhao D; Chen P; Yang H; Wu Y; Zeng X; Zhao Y; Wen Y; Zhao X; Liu X; Wei Y; Li Y
    Oncol Rep; 2013 Jan; 29(1):199-204. PubMed ID: 23129111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.